Halana Rothbort
Psychiatry · Manhasset, NYNPI 1255311403
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 495 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 495 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$1K
- Supernus Pharmaceuticals, Inc.$999
- Corium, LLC$960
- Sunovion Pharmaceuticals Inc.$720
- Takeda Pharmaceuticals U.S.A., Inc.$705
- AbbVie$696
- plus $5K from 20 others
What the payments were for
- Food & beverage$10,583100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 53 | $1,092 |
| Supernus Pharmaceuticals, Inc. | 40 | $999 |
| Corium, LLC | 42 | $960 |
| Sunovion Pharmaceuticals Inc. | 35 | $720 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $705 |
| AbbVie | 29 | $696 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $680 |
| Neos Therapeutics, LP | 33 | $597 |
| Otsuka America Pharmaceutical, Inc. | 25 | $447 |
| Alkermes, Inc. | 15 | $430 |
| Lundbeck LLC | 25 | $428 |
| Axsome Therapeutics, Inc. | 18 | $427 |
| Teva Pharmaceuticals USA, Inc. | 11 | $369 |
| Tris Pharma Inc | 18 | $331 |
| Collegium Pharmaceutical, Inc. | 16 | $330 |
| Johnson & Johnson | 7 | $251 |
| Alfasigma USA, Inc. | 10 | $237 |
| Arbor Pharmaceuticals, Inc. | 13 | $226 |
| Adlon Therapeutics L.p. | 10 | $184 |
| Vertical Pharmaceuticals, LLC | 7 | $119 |
| Shire North American Group Inc | 5 | $90 |
| Almatica Pharma LLC | 4 | $89 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Neurocrine Biosciences, Inc. | 3 | $71 |
| Neuronetics, Inc. | 1 | $28 |
| Biogen | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,598 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 24 | $240 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 26 | $170 |
| Aripiprazole | 12 | $105 |
| Quetiapine Fumarate | 15 | $69 |
| Benztropine Mesylate | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Manhasset
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.